-
1
-
-
0026520359
-
Prediction of mortality in patients with cystic fibrosis
-
Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187-1191.
-
(1992)
N Engl J Med
, vol.326
, Issue.18
, pp. 1187-1191
-
-
Kerem, E.1
Reisman, J.2
Corey, M.3
Canny, G.J.4
Levison, H.5
-
2
-
-
0035865730
-
Predictive 5-year survivorship model of cystic fibrosis
-
DOI 10.1093/aje/153.4.345
-
Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153(4): 345-352. (Pubitemid 32144560)
-
(2001)
American Journal of Epidemiology
, vol.153
, Issue.4
, pp. 345-352
-
-
Liou, T.G.1
Adler, F.R.2
Fitzsimmons, S.C.3
Cahill, B.C.4
Hibbs, J.R.5
Marshall, B.C.6
-
3
-
-
0031471090
-
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
-
DOI 10.1016/S0022-3476(97)70025-8
-
Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr. 1997;131(6): 809-814. (Pubitemid 28027602)
-
(1997)
Journal of Pediatrics
, vol.131
, Issue.6
, pp. 809-814
-
-
Corey, M.1
Edwards, L.2
Levison, H.3
Knowles, M.4
-
4
-
-
0031950258
-
Risk of death in cystic fibrosis patients with severely compromised lung function
-
Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest. 1998;113(5):1230-1234.
-
(1998)
Chest
, vol.113
, Issue.5
, pp. 1230-1234
-
-
Milla, C.E.1
Warwick, W.J.2
-
5
-
-
0141816759
-
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial
-
Macrolide Study Group
-
Saiman L, Marshall BC, Mayer-Hamblett N, et al; Macrolide Study Group. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003;290(13):1749-1756.
-
(2003)
JAMA
, vol.290
, Issue.13
, pp. 1749-1756
-
-
Saiman, L.1
Marshall, B.C.2
Mayer-Hamblett, N.3
-
6
-
-
0028914667
-
Effect of high-dose ibuprofen in patients with cystic fibrosis
-
Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332(13):848-854.
-
(1995)
N Engl J Med
, vol.332
, Issue.13
, pp. 848-854
-
-
Konstan, M.W.1
Byard, P.J.2
Hoppel, C.L.3
Davis, P.B.4
-
7
-
-
0028129568
-
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis
-
Pulmozyme Study Group
-
Fuchs HJ, Borowitz DS, Christiansen DH, et al; Pulmozyme Study Group. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994;331(10):637-642.
-
(1994)
N Engl J Med
, vol.331
, Issue.10
, pp. 637-642
-
-
Fuchs, H.J.1
Borowitz, D.S.2
Christiansen, D.H.3
-
8
-
-
0035666058
-
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities
-
Pulmozyme Early Intervention Trial Study Group
-
Quan JM, Tiddens HAWM, Sy JP, et al; Pulmozyme Early Intervention Trial Study Group. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr. 2001; 139(6):813-820.
-
(2001)
J Pediatr
, vol.139
, Issue.6
, pp. 813-820
-
-
Quan, J.M.1
Tiddens, H.A.W.M.2
Sy, J.P.3
-
9
-
-
30944466084
-
A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
-
National Hypertonic Saline in Cystic Fibrosis Study Group
-
Elkins MR, Robinson M, Rose BR, et al; National Hypertonic Saline in Cystic Fibrosis Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006;354(3):229-240.
-
(2006)
N Engl J Med
, vol.354
, Issue.3
, pp. 229-240
-
-
Elkins, M.R.1
Robinson, M.2
Rose, B.R.3
-
10
-
-
0033531143
-
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
-
Cystic Fibrosis Inhaled Tobramycin Study Group
-
Ramsey BW, Pepe MS, Quan JM, et al; Cystic Fibrosis Inhaled Tobramycin Study Group. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med. 1999;340(1):23-30.
-
(1999)
N Engl J Med
, vol.340
, Issue.1
, pp. 23-30
-
-
Ramsey, B.W.1
Pepe, M.S.2
Quan, J.M.3
-
11
-
-
77955321247
-
-
Cystic Fibrosis Foundation Bethesda, MD: Cystic Fibrosis Foundation
-
Cystic Fibrosis Foundation. Patient Registry Annual Data Report 2008. Bethesda, MD: Cystic Fibrosis Foundation; 2009:10.
-
(2009)
Patient Registry Annual Data Report 2008
, pp. 10
-
-
-
12
-
-
34548720965
-
National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia
-
Pham JC, Kelen GD, Pronovost PJ. National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia. Acad Emerg Med. 2007;14(10):856-863.
-
(2007)
Acad Emerg Med
, vol.14
, Issue.10
, pp. 856-863
-
-
Pham, J.C.1
Kelen, G.D.2
Pronovost, P.J.3
-
13
-
-
54949144677
-
Management of asymptomatic patients with severe non-ischaemic mitral regurgitation: Are practices consistent with guidelines?
-
Detaint D, Iung B, Lepage L, et al. Management of asymptomatic patients with severe non-ischaemic mitral regurgitation: are practices consistent with guidelines? Eur J Cardiothorac Surg. 2008;34(5):937-942.
-
(2008)
Eur J Cardiothorac Surg
, vol.34
, Issue.5
, pp. 937-942
-
-
Detaint, D.1
Iung, B.2
Lepage, L.3
-
14
-
-
68849102181
-
Failure of guideline adherence for intervention in patients with severe mitral regurgitation
-
Bach DS, Awais M, Gurm HS, Kohnstamm S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol. 2009; 54(9):860-865.
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.9
, pp. 860-865
-
-
Bach, D.S.1
Awais, M.2
Gurm, H.S.3
Kohnstamm, S.4
-
15
-
-
0032721879
-
Why don't physicians follow clinical practice guidelines? A framework for improvement
-
Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA. 1999;282(15):1458-1465.
-
(1999)
JAMA
, vol.282
, Issue.15
, pp. 1458-1465
-
-
Cabana, M.D.1
Rand, C.S.2
Powe, N.R.3
-
16
-
-
36248953255
-
Cystic fibrosis pulmonary guidelines: Chronic medications for maintenance of lung health
-
Cystic Fibrosis Foundation, Pulmonary Therapies Committee
-
Flume PA, O'Sullivan BP, Robinson KA, et al; Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176 (10):957-969.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, Issue.10
, pp. 957-969
-
-
Flume, P.A.1
O'Sullivan, B.P.2
Robinson, K.A.3
-
17
-
-
1642318039
-
Study designs for PDSA quality improvement research
-
Speroff T, O'Connor GT. Study designs for PDSA quality improvement research. Qual Manag Health Care. 2004;13(1):17-32.
-
(2004)
Qual Manag Health Care
, vol.13
, Issue.1
, pp. 17-32
-
-
Speroff, T.1
O'Connor, G.T.2
-
18
-
-
0032608541
-
Evidence-based guidelines and critical pathways for quality improvement
-
Bergman DA. Evidence-based guidelines and critical pathways for quality improvement. Pediatrics. 1999;103(1)(suppl E):225-232.
-
(1999)
Pediatrics
, vol.103
, Issue.1 SUPPL. E
, pp. 225-232
-
-
Bergman, D.A.1
-
19
-
-
77649218992
-
Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: Findings from the Get with the Guidelines quality-improvement program
-
Lewis WR, Ellrodt AG, Peterson E, et al. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the Get With the Guidelines quality-improvement program. Circ Cardiovasc Qual Outcomes. 2009;2(6):633-641.
-
(2009)
Circ Cardiovasc Qual Outcomes
, vol.2
, Issue.6
, pp. 633-641
-
-
Lewis, W.R.1
Ellrodt, A.G.2
Peterson, E.3
-
20
-
-
33845200385
-
Improved adherence to Swedish national guidelines for acute myocardial infarction: The Quality Improvement in Coronary Care (QUICC) study
-
QUICC Study Group
-
Carlhed R, Bojestig M, Wallentin L, et al; QUICC Study Group. Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study. Am Heart J. 2006;152(6):1175-1181.
-
(2006)
Am Heart J
, vol.152
, Issue.6
, pp. 1175-1181
-
-
Carlhed, R.1
Bojestig, M.2
Wallentin, L.3
-
21
-
-
77949512145
-
Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative
-
Quality Improvement in Coronary Care Study Group
-
Carlhed R, Bojestig M, Peterson A, Aberg C, Garmo H, Lindahl B; Quality Improvement in Coronary Care Study Group. Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative. Circ Cardiovasc Qual Outcomes. 2009;2(5):458-464.
-
(2009)
Circ Cardiovasc Qual Outcomes
, vol.2
, Issue.5
, pp. 458-464
-
-
Carlhed, R.1
Bojestig, M.2
Peterson, A.3
Aberg, C.4
Garmo, H.5
Lindahl, B.6
|